Louis Gleckel M.D. is Director at ProPhase Labs, Inc. (PRPH). They have made 2 open-market trades across 1 company since 2020, most recently 2020-08-13.
CIK 0001164762
2 open-market purchases totalling $313K since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PRPH | 273,840 | $100K |
Shares reported on the most recent Form 4, priced at the 2020-08-17 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.